Literature DB >> 3722328

Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.

M M Esiri, J S Bevan, C W Burke, C B Adams.   

Abstract

We performed a quantitative study using a point-counting technique at the light microscope level of the fibrous tissue content of PRL-secreting and nonfunctioning pituitary macroadenomas from patients treated or untreated with bromocriptine (BC) before surgery. There was a significant increase in the fibrous tissue content of PRL-secreting, but not nonfunctioning, tumors after BC treatment. The extent of the increase in fibrous tissue in prolactinomas correlated with the duration of treatment with BO.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722328     DOI: 10.1210/jcem-63-2-383

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Authors:  Maria Menucci; Alfredo Quiñones-Hinojosa; Peter Burger; Roberto Salvatori
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

2.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Pituitary gland: can prolactinomas be cured medically?

Authors:  Mark E Molitch
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

Review 4.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

5.  The management of pituitary tumours and post-operative visual deterioration.

Authors:  C B Adams
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

6.  Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection.

Authors:  Michael E Sughrue; Edward F Chang; J Blake Tyrell; Sandeep Kunwar; Charles B Wilson; Lewis S Blevins
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.

Authors:  Niraj Mohan; Yi Yan Chia; Giap Hean Goh; Eric Ting; Kejia Teo; Tseng Tsai Yeo
Journal:  BMJ Case Rep       Date:  2017-11-03

Review 8.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

9.  Commentary: "Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery".

Authors:  Lukas Andereggen; Emanuel Christ
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

10.  Angiogenesis in Endocrine Neoplasms.

Authors:  Martin Jugenburg; Kalman Kovacs; Ivan Jugenburg; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.